Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IDI2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CASKIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
STAMBPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BABAM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAPK9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLX1A-SULT1A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PCGF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UFD1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NTMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXorf40B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCMT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VAMP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on